ClearPoint Neuro Inc vs Invesco NASDAQ 100 ETF — how do they compare? ClearPoint Neuro Inc trades at $15.86 (market cap $478.63M), while Invesco NASDAQ 100 ETF trades at $295.18. The key difference: Invesco NASDAQ 100 ETF is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | QQQM | |
|---|---|---|
Market Cap | $478.63M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $29.60 | $307.23 |
52-Week Low | $8.66 | $228.02 |
Enterprise Value | $506.63M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QQQM, tracking the Nasdaq-100, trades at $293.06, down 1.89% on the day amid a bearish technical signal from moving averages. The ETF's valuation ratios are unavailable, but it offers exposure to major tech firms, with recent news highlighting SpaceX's inclusion in the index. Support lies at $292, with resistance at $295.
The outlook is cautious due to stretched valuations and AI competition risks, but QQQM's lower expense ratio than QQQ provides a cost edge. Key risks include market volatility and sector concentration, while analyst sentiment is mixed, with some seeing long-term growth potential from AI infrastructure spending.
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.
Read more on QQQM →